Transforming Growth Factor Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

PUBLISHED: November 23, 2023

PAGES: 345 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Fairfield Market Research, a premier market research firm, has unveiled its latest report on the Transforming Growth Factor (TGF) market, projecting a robust growth trajectory. The global revenue for TGF market was recorded at US$ 390 million in 2024, and it is poised to reach valuation of nearly US$ 740 million by the end of 2031.

Fueling Global TGF Market Growth

Specialty Products and Asia Pacific Market Expansion: While many businesses in the TGF market offer a range of products and services, there is a growing focus on being a supplier of GMP-grade products and reagents. This specialized approach ensures higher product quality and a well-established distribution network. The life sciences industry, which boasts one of the highest R&D spending levels globally, is expected to continue increasing its investment. Furthermore, the shift in R&D and technology investments from North America and Europe to Asia Pacific, particularly in countries like India, with its skilled labor force and government incentives, is expected to drive market growth.

Potential Challenges

Lack of Skilled Professionals and High Product Costs: The development of novel, high-cost products to meet the increasingly complex requirements of life sciences researchers has created hesitation among consumers, particularly research teams with budget constraints. Additionally, certain growth factors come with a hefty price tag, limiting access for many laboratories. A shortage of skilled professionals in the research and development sector, primarily due to low pay scales, demanding duties, and insufficient training, poses another challenge. This shortage of experienced individuals, along with limitations in research facilities, may hamper global market growth.

Country-wise Insights

Booming U.S. Market: The U.S. market accounted for approximately 94.1% of the North America market in 2022. Increasing capital expenditure on pharmaceutical manufacturing and a growing number of established manufacturers within the U.S. have driven market sales. The commercialization of personalized pharmaceutical products and intensified research and development efforts in novel biologics are expected to further boost the market in the country.

Lucrative German Market: Germany held about 28.2% market share in the Europe market in 2022. The rising cost of healthcare per capita globally has significantly affected healthcare spending. The presence of production facilities for growth factor products in Germany has improved product availability. Moreover, major companies are engaging in mergers and acquisitions to expand their product portfolios, contributing to market growth.

Emerging Chinese Market: China dominated the East Asia market with a market share of approximately 46.8% in 2022. China's growing economy, coupled with a surge in Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) activities, has propelled market sales. Economic, social, and environmental shifts have contributed to these developments, reducing imbalances in the country's growth structure.

Competitive Landscape

Market players are employing strategies such as acquisitions, mergers, expansions, and product launches to enhance their market presence. Asia Pacific is witnessing significant Research and Development (R&D) investments by corporations aiming to diversify their product offerings and capture market share in emerging economies.

Key Market Players

Thermo Fisher Scientific
Lonza Group AG
Merck KGaA
F. Hoffmann-La Roche Ltd
Abcam plc.
Bio-Techne.
Sartorius CellGenix GmbH
Proteintech Group, Inc.
PeproTech Inc.
Cell Signaling Technology, Inc.
Meridian Bioscience Inc.
Applied Biological Materials (abm), Inc.
Akron Biotech
Leadgene Biomedical, Inc
GE Healthcare

Key Segments Covered in Transforming Growth Factor Industry Research

Product:

Activin
Bone Morphogenetic Proteins (BMPs)
TGF-beta Proteins

Grade:

GMP Grade
Non-GMP Grade

Application:

Oncology Research
Hematology Research
Wound Healing Research
Dermatology Research
Cardiovascular Disease & Diabetes
Cell Therapy and Ex vivo Manufacturing
Others

End User:

Pharmaceutical and Biotechnology Companies
Research Centers & Academic Institutes
CMO and CDMO

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Transforming Growth Factor Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Transforming Growth Factor Market Outlook, 2018 - 2031

3.1. Global Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Activin
  - 3.1.1.2. Bone Morphogenetic Proteins (BMPs)
  - 3.1.1.3. TGF-beta Proteins
3.2. Global Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. GMP Grade
  - 3.2.1.2. Non-GMP Grade
3.3. Global Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Oncology Research
  - 3.3.1.2. Hematology Research
  - 3.3.1.3. Wound Healing Research
  - 3.3.1.4. Dermatology Research
  - 3.3.1.5. Cardiovascular Disease & Diabetes
  - 3.3.1.6. Cell Therapy and Ex vivo Manufacturing
  - 3.3.1.7. Others
3.4. Global Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Pharmaceutical and Biotechnology Companies
  - 3.4.1.2. Research Centers & Academic Institutes
  - 3.4.1.3. CMO and CDMO
3.5. Global Transforming Growth Factor Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Transforming Growth Factor Market Outlook, 2018 - 2031

4.1. North America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Activin
  - 4.1.1.2. Bone Morphogenetic Proteins (BMPs)
  - 4.1.1.3. TGF-beta Proteins
4.2. North America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. GMP Grade
  - 4.2.1.2. Non-GMP Grade
4.3. North America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Oncology Research
  - 4.3.1.2. Hematology Research
  - 4.3.1.3. Wound Healing Research
  - 4.3.1.4. Dermatology Research
  - 4.3.1.5. Cardiovascular Disease & Diabetes
  - 4.3.1.6. Cell Therapy and Ex vivo Manufacturing
  - 4.3.1.7. Others
4.4. North America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Pharmaceutical and Biotechnology Companies
  - 4.4.1.2. Research Centers & Academic Institutes
  - 4.4.1.3. CMO and CDMO
4.5. North America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.2. U.S. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.3. U.S. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031 by End User
  - 4.5.1.4. U.S. Transforming Growth Factor Market, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.5. Canada Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.6. Canada Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.7. Canada Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 4.5.1.8. Canada Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Transforming Growth Factor Market Outlook, 2018 - 2031

5.1. Europe Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Activin
  - 5.1.1.2. Bone Morphogenetic Proteins (BMPs)
  - 5.1.1.3. TGF-beta Proteins
5.2. Europe Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. GMP Grade
  - 5.2.1.2. Non-GMP Grade
5.3. Europe Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Oncology Research
  - 5.3.1.2. Hematology Research
  - 5.3.1.3. Wound Healing Research
  - 5.3.1.4. Dermatology Research
  - 5.3.1.5. Cardiovascular Disease & Diabetes
  - 5.3.1.6. Cell Therapy and Ex vivo Manufacturing
  - 5.3.1.7. Others
5.4. Europe Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Pharmaceutical and Biotechnology Companies
  - 5.4.1.2. Research Centers & Academic Institutes
  - 5.4.1.3. CMO and CDMO
5.5. Europe Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.2. Germany Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.3. Germany Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.4. Germany Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.5. U.K. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.6. U.K. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.7. U.K. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.8. U.K. Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.9. France Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.10. France Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.11. France Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.12. France Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.13. Italy Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.14. Italy Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.15. Italy Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.16. Italy Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.17. Turkey Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.18. Turkey Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.19. Turkey Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.20. Turkey Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.21. Russia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.22. Russia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.23. Russia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.24. Russia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.25. Rest of Europe Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.26. Rest of Europe Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.27. Rest of Europe Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 5.5.1.28. Rest of Europe Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Transforming Growth Factor Market Outlook, 2018 - 2031

6.1. Asia Pacific Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Activin
  - 6.1.1.2. Bone Morphogenetic Proteins (BMPs)
  - 6.1.1.3. TGF-beta Proteins
6.2. Asia Pacific Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. GMP Grade
  - 6.2.1.2. Non-GMP Grade
6.3. Asia Pacific Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Oncology Research
  - 6.3.1.2. Hematology Research
  - 6.3.1.3. Wound Healing Research
  - 6.3.1.4. Dermatology Research
  - 6.3.1.5. Cardiovascular Disease & Diabetes
  - 6.3.1.6. Cell Therapy and Ex vivo Manufacturing
  - 6.3.1.7. Others
6.4. Asia Pacific Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Pharmaceutical and Biotechnology Companies
  - 6.4.1.2. Research Centers & Academic Institutes
  - 6.4.1.3. CMO and CDMO
6.5. Asia Pacific Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.2. China Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.3. China Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.4. China Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.5. Japan Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.6. Japan Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.7. Japan Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.8. Japan Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.9. South Korea Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.10. South Korea Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.11. South Korea Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.12. South Korea Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.13. India Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.14. India Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.15. India Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.16. India Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.17. Southeast Asia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.18. Southeast Asia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.19. Southeast Asia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.20. Southeast Asia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Transforming Growth Factor Market Outlook, 2018 - 2031

7.1. Latin America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Activin
  - 7.1.1.2. Bone Morphogenetic Proteins (BMPs)
  - 7.1.1.3. TGF-beta Proteins
7.2. Latin America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.3. Latin America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Oncology Research
  - 7.3.1.2. Hematology Research
  - 7.3.1.3. Wound Healing Research
  - 7.3.1.4. Dermatology Research
  - 7.3.1.5. Cardiovascular Disease & Diabetes
  - 7.3.1.6. Cell Therapy and Ex vivo Manufacturing
  - 7.3.1.7. Others
7.4. Latin America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Pharmaceutical and Biotechnology Companies
  - 7.4.1.2. Research Centers & Academic Institutes
  - 7.4.1.3. CMO and CDMO
7.5. Latin America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.2. Brazil Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.3. Brazil Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.4. Brazil Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.5. Mexico Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.6. Mexico Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.7. Mexico Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.8. Mexico Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.9. Argentina Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.10. Argentina Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.11. Argentina Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.12. Argentina Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Transforming Growth Factor Market Outlook, 2018 - 2031

8.1. Middle East & Africa Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Activin
  - 8.1.1.2. Bone Morphogenetic Proteins (BMPs)
  - 8.1.1.3. TGF-beta Proteins
8.2. Middle East & Africa Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. GMP Grade
  - 8.2.1.2. Non-GMP Grade
8.3. Middle East & Africa Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Oncology Research
  - 8.3.1.2. Hematology Research
  - 8.3.1.3. Wound Healing Research
  - 8.3.1.4. Dermatology Research
  - 8.3.1.5. Cardiovascular Disease & Diabetes
  - 8.3.1.6. Cell Therapy and Ex vivo Manufacturing
  - 8.3.1.7. Others
8.4. Middle East & Africa Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Pharmaceutical and Biotechnology Companies
  - 8.4.1.2. Research Centers & Academic Institutes
  - 8.4.1.3. CMO and CDMO
8.5. Middle East & Africa Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.2. GCC Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.3. GCC Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.4. GCC Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.5. South Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.6. South Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.7. South Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.8. South Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.9. Egypt Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.10. Egypt Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.11. Egypt Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.12. Egypt Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.13. Nigeria Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.14. Nigeria Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.15. Nigeria Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.16. Nigeria Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Application vs by Grade Heatmap
9.2. Manufacturer vs by Grade Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Thermo Fisher Scientific
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Lonza Group AG
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Merck KGaA
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. F. Hoffmann-La Roche Ltd
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Abcam plc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Bio-Techne.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Sartorius CellGenix GmbH
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Proteintech Group, Inc.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. PeproTech Inc.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Cell Signaling Technology, Inc.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Meridian Bioscience Inc.
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Applied Biological Materials (abm), Inc.
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. Akron Biotech
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Leadgene Biomedical, Inc
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. GE Healthcare
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development